160 related articles for article (PubMed ID: 17978296)
1. East meets west in the treatment of gastric cancer.
Cunningham D; Chua YJ
N Engl J Med; 2007 Nov; 357(18):1863-5. PubMed ID: 17978296
[No Abstract] [Full Text] [Related]
2. The role of S-1 in the treatment of gastric cancer.
Kubota T
Br J Cancer; 2008 Apr; 98(8):1301-4. PubMed ID: 18362933
[TBL] [Abstract][Full Text] [Related]
3. Treatment of gastric cancer in Asia: the missing link.
Nishida T
Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
[No Abstract] [Full Text] [Related]
4. Adjuvant S-1 chemotherapy for gastric cancer and peritoneal wash.
Spiliotis J; Zoras O
World J Surg; 2011 Feb; 35(2):468-9; author reply 470-1. PubMed ID: 20857104
[No Abstract] [Full Text] [Related]
5. [The Clinical Outcome of Conversion Surgery for Unresectable Gastric Cancers in Our Institution].
Gunji H; Sakuramoto S; Aratani K; Chuman M; Wakata M; Miyawaki Y; Sato H; Okamoto K; Yamaguchi S; Koyama I
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1458-1460. PubMed ID: 29394667
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience.
Yen HH; Chen CN; Yeh CC; Lai IR
World J Surg Oncol; 2021 Apr; 19(1):124. PubMed ID: 33865416
[TBL] [Abstract][Full Text] [Related]
7. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
Duh D; Warnez M
J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
[No Abstract] [Full Text] [Related]
8. [A case of postoperative gastric cancer responding to adjuvant chemotherapy with TS-1--a novel oral formation of 5-fluorouracil].
Yamada T; Morishita M; Yoshida K; Kinoshita S; Yokoi K; Nakamura M; Morita K; Harada T; Yagi S; Kitagawa S; Nakagawa M
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1909-12. PubMed ID: 11729486
[TBL] [Abstract][Full Text] [Related]
9. Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
Hasegawa H; Fujitani K; Kurokawa Y; Hirao M; Nakazuru S; Mita E; Tsujinaka T
Chemotherapy; 2010; 56(6):436-43. PubMed ID: 21088394
[TBL] [Abstract][Full Text] [Related]
10. High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients.
Nakazawa N; Sohda M; Ide M; Shimoda Y; Ubukata Y; Kuriyama K; Hara K; Sano A; Sakai M; Yokobori T; Ogawa H; Oyama T; Shirabe K; Saeki H
Oncology; 2021; 99(11):732-739. PubMed ID: 34392246
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy-mediated tumor regression in a patient with stage IV stomach small cell cancer].
Nagase H; Makari Y; Iijima S; Sakamoto T; Miyo M; Doi T; Hoshi M; Miyake Y; Oshima S; Ikeda K; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2381-3. PubMed ID: 23268084
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.
Okuyama T; Korenaga D; Edagawa A; Itoh S; Oki E; Kawanaka H; Ikeda Y; Kakeji Y; Tateishi M; Tsujitani S; Takenaka K; Maehara Y
Surg Today; 2012 Aug; 42(8):734-40. PubMed ID: 22278622
[TBL] [Abstract][Full Text] [Related]
13. The Capsule Endoscopy Findings in S-1-induced Enteritis with Severe Diarrhea during Adjuvant Chemotherapy for Gastric Cancer (with Video).
Ota K; Takeuchi T; Kodama K; Ozaki H; Harada S; Kojima Y; Nouda S; Goto M; Higuchi K
Intern Med; 2018 Feb; 57(3):343-344. PubMed ID: 29093427
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
15. To resect or not resect in metastatic gastric cancer: that is the question!
Lordick F
Gastric Cancer; 2012 Jul; 15(3):229-31. PubMed ID: 22282136
[No Abstract] [Full Text] [Related]
16. [A case of advanced gastric cancer treated with S-1 and S-1/paclitaxel showing complete response twice].
Matsuyama J; Naitou A; Hiraki M; Matsumoto S; Hashimoto K; Yokoyama S; Morita S; Morimoto T; Fukushima Y; Nishishou I; Nomura T; Sasaki Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2297-9. PubMed ID: 20037401
[TBL] [Abstract][Full Text] [Related]
17. [A case of advanced gastric cancer with multiple liver metastasis responding to S-1 and irinotecan combination therapy].
Kuga T; Oka K; Yamashita A; Fujii Y; Hanashima M; Hamano K
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1333-6. PubMed ID: 21829075
[No Abstract] [Full Text] [Related]
18. [A case of remnant gastric cancer responding to neoadjuvant TS-1 therapy].
Deguchi Y; Nashimoto A; Yabusaki H; Tanaka O; Sasaki J
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1449-52. PubMed ID: 11681256
[TBL] [Abstract][Full Text] [Related]
19. Oral treatment for gastric cancer: new choices, better choices?
Cascinu S
Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239
[No Abstract] [Full Text] [Related]
20. [A case with multiple liver metastases of gastric cancer responding completely to S-1 therapy].
Nakazawa K; Yamaki K; Morisaki T; Hirakawa T; Hasegawa T; Tachimori A; Yamagata S; Kanehara I; Ako E; Enomoto J; Nishimura S; Taenaka N
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1377-80. PubMed ID: 20647731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
